Makhzoumi Mohamad 4
4 · Korro Bio, Inc. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Korro Bio (KRRO) 10% Owner Makhzoumi Buys ~450K Shares
What Happened
Makhzoumi Mohamad, reported as a 10% owner, purchased a total of 450,045 economic interests in Korro Bio on March 10, 2026. The filing shows: 207,100 shares acquired at $11.11 each for $2,300,881 (direct purchase from the issuer per a Subscription Agreement) and 242,945 units reported as derivative/pre‑funded warrants at $11.11 each for $2,698,876. Combined consideration equals $4,999,757. These were purchases (acquisitions), which are generally considered more informative than routine sales.
Key Details
- Transaction date: 2026-03-10 (Filed: 2026-03-12) — filing appears timely under Section 16 rules.
- Items purchased:
- 207,100 common shares @ $11.11 = $2,300,881 (F1: acquired from issuer under Subscription Agreement dated Mar 9, 2026).
- 242,945 pre‑funded warrants (derivative) @ $11.11 = $2,698,876 (total 450,045 interest units; combined value $4,999,757).
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Notable footnotes:
- F1: Purchase from issuer per Subscription Agreement (Mar 9, 2026).
- F2: Reporting person is a manager of NEA 17 GP, LLC (general partner of related NEA entities) and disclaims beneficial ownership of securities held by NEA 17 where no pecuniary interest exists.
- F3: The pre‑funded warrants are exercisable, but exercise may be limited so the holder does not exceed 9.99% ownership (holder may raise that cap to as much as 19.99% with 61 days' prior notice).
- Filing timeliness: Filed two days after the transaction date; not marked late in the provided data.
Context
Pre‑funded warrants are essentially a right to acquire common stock by paying a small additional amount on exercise; they are reported as derivatives here. The F3 cap means the holder cannot exercise the warrants if doing so would push ownership above 9.99% (unless they notify the company and raise the cap). F2 indicates some holdings or interests may be held through investment entities (NEA), and the reporting person disclaims beneficial ownership where they lack a pecuniary interest. This filing documents purchases (acquisitions) rather than sales; purchases are often watched by investors as a potentially bullish signal, but filings are factual and do not state the insider’s motivation.
Insider Transaction Report
- Purchase
Common Stock
[F1][F2]2026-03-10$11.11/sh+207,100$2,300,881→ 1,297,893 total(indirect: See Note 2) - Purchase
Pre-Funded Warrants
[F1][F3][F2]2026-03-10$11.11/sh+242,945$2,698,876→ 242,945 total(indirect: See Note 2)Exercise: $0.00→ Common Stock (242,945 underlying)
Footnotes (3)
- [F1]Acquired from the Issuer on March 10, 2026 pursuant to a Subscription Agreement dated March 9, 2026.
- [F2]The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
- [F3]The Pre-Funded Warrants are exercisable at any time after their issuance; provided, however, that the Pre-Funded Warrants may not be exercised to the extent such exercise would cause the number of shares of the Issuer's Common Stock owned by the holder (together with its affiliates and certain other related parties) to exceed 9.99% of the total number of shares of the Issuer's Common Stock immediately after giving effect to such exercise, which percentage may be increased or decreased at the option of the holder upon 61 days' prior notice to the Issuer, not to exceed 19.99%.